Marc Funk, Recipharm CEO
October 12, 2023 12:42 PM EDTUpdated October 13, 09:44 AM
Manufacturing

Re­ci­pharm CEO an­tic­i­pates 2024 will be ‘as hard’ for CD­MOs, strat­e­gy will be key for en­durance

Anna Brown

News Reporter

Re­ci­pharm CEO Marc Funk an­tic­i­pates 2024 to be just as chal­leng­ing for CD­MOs in terms of find­ing op­por­tu­ni­ties for growth due to wider eco­nom­ic chal­lenges …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times